CCO The Calmer Co FY25 revenue hits $8 million, up 86% on FY24 The Calmer Co (ASX:CCO) has wrapped up FY25 with preliminary unaudited revenue surpassing $8 million, which marks the third year in a row the kava-selling company has posted upward-trending year-end results.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest h... Isaac McIntyre 03 Jul 2025 16:23 (AEST) ASX News The Watchlist Healthcare Drug Manufacturers - Major
CCO The Calmer Co. pens agreement with Leilo In this Watchlist interview, The Calmer Co (ASX:CCO) CEO, Zane Yoshida, and Leilo Founder and CEO, Sol Broady, joins HotCopper’s Sean Boss to discuss a recently penned non-binding MOU between the two companies where CCO will aim to supply high grade noble kava powders, sourced fro... Sean Boss 07 May 2025 11:00 (AEST) ASX News The Watchlist Healthcare Drug Manufacturers - Major
CCO The Calmer Co's Fiji Kava product hitting Woolworths stores The Calmer Co International Ltd is expanding its dominance in Australia's retail sector with the entry of Fiji Kava into Woolworths Caroline Smith 16 Apr 2025 12:56 (AEST) ASX News Consumer Cyclical Healthcare Drug Manufacturers - Major
CCO The Calmer Co inks deal with Woolworths The Calmer Co. (ASX:CCO) has inked a huge new agreement with supermarket giant Woolworths (ASX:WOW) which will see the company’s 50-gram Instant Kava hit shelves in Australia as soon as the middle of the year.Listen to the HotCopper podcast for in-depth discussions and insights on... Isaac McIntyre 16 Apr 2025 09:59 (AEST) ASX News The Watchlist Healthcare Drug Manufacturers - Major
SIG Chemist Warehouse's $34B backdoor ASX listing is today. What does it all mean? We've arrived at the big day – thanks to a $34B merger with Sigma Healthcare, Chemist Warehouse is now listed on the ASX from open today. Isaac McIntyre 13 Feb 2025 09:50 (AEDT) ASX 200 ASX News Healthcare Drug Manufacturers - Major
